Knowledge

Infantile hemangioma

Source πŸ“

735:-like structure, whether it was present at or around birth or appeared later in life. In 1982, Mulliken and Glowacki proposed a new classification system for vascular anomalies which has been widely accepted and adopted by the International Society for the Study of Vascular Anomalies. This classification system was recently updated in 2015. The classification of vascular anomalies is now based upon cellular features, natural history, and clinical behavior of the lesion. Vascular anomalies are divided into vascular tumors/neoplasms which include infantile hemangiomas, and vascular malformations that include entities with enlarged or abnormal vessels such as capillary malformations (port wine stains), venous malformations, and lymphatic malformations. In 2000, GLUT-1, a specific immunohistochemical marker, was found to be positive in IHs and negative in other vascular tumors or malformations. This marker has revolutionized the ability to distinguish between infantile hemangioma and other vascular anomalies. 627:
for treatment include functional impairment (i.e. visual or feeding compromise), bleeding, potentially life-threatening complications (airway, cardiac, or hepatic disease), and risk of long-term or permanent disfigurement. Large IHs can leave visible skin changes secondary to significant stretching of the skin or alteration of surface texture. When they interfere with vision, breathing, or threaten significant disfigurement (most notably facial lesions, and in particular, nose and lips), they are usually treated. Medical therapies are most effective when used during the period of most significant hemangioma growth, which corresponds to the first 5 months of life. Ulcerated hemangiomas, a subset of lesions requiring therapy, are usually treated by addressing wound care, pain, and hemangioma growth.
609:, IHs show a well-circumscribed lesion with intermediate and increased signal intensity on T1- and T2-weighted sequences, respectively, and strong enhancement after gadolinium injections, with fast-flow vessels. Tissue for diagnosis can be obtained via fine-needle aspiration, skin biopsy, or excisional biopsy. Under the microscope, IHs are unencapsulated aggregates of closely packed, thin-walled capillaries, usually with endothelial lining. Blood-filled vessels are separated by scant connective tissue. Their lumina may be thrombosed and organized. Hemosiderin pigment deposition due to vessel rupture may be observed. The GLUT-1 histochemical marker can be helpful in distinguishing IHs from other items on the differential diagnosis, such as vascular malformations. 601:), and/or cytology or histopathology are needed to confirm the diagnosis. IHs are usually absent at birth or a small area of pallor, telangiectasias, or duskiness may be seen. A fully formed mass at birth usually indicates a different diagnosis. Superficial hemangiomas in the upper dermis have a bright-red strawberry color, whereas those in the deep dermis and subcutis, deep hemangiomas, may appear blue and be firm or rubbery on palpation. Mixed hemangiomas can have both features. A minimally proliferative IH is an uncommon type that presents with fine macular telangiectasias with an occasional bright-red, papular, proliferative component. Minimally proliferative IHs are more common in the lower body. 605:
the growth completed by 3 months. Finally, IHs involute over a period of years. The exceptions to these growth characteristics include minimally proliferative His, which do not substantially proliferate and large, deep IHs in which noticeable growth starts later and lasts longer. If the diagnosis is not clear based on physical examination and growth history (most often in deep hemangiomas with little cutaneous involvement), then either imaging or histopathology can help confirm the diagnosis. On Doppler ultrasound, an IH in the proliferative phase appears as a high-flow, soft-tissue mass usually without direct arteriovenous shunting. On
406:
venous prominence. Deep hemangiomas have a tendency to develop a little later than superficial hemangiomas, and may have longer and later proliferative phases, as well. Deep hemangiomas rarely ulcerate, but can cause issues depending on their location, size, and growth. Deep hemangiomas near sensitive structures can cause compression of softer surrounding structures during the proliferative phase, such as the external ear canal and the eyelid. Mixed hemangiomas are simply a combination of superficial and deep hemangiomas, and may not be evident for several months. Patients may have any combination of superficial, deep, or mixed IHs.
571: 663:
addition, no difference was detected between these two agents and their ability to reduce hemangioma size; however, whether a difference in safety exists is not clear. All of these results were based on moderate- to low-quality evidence, thus further randomized, controlled trials with large populations of children are needed to further evaluate these therapies. This review concluded that for now, no evidence challenges oral propranalol as the standard systemic therapy for treatment of these lesions.
367: 723:
airway and high-output heart failure may lessen with involution of a hepatic hemangioma and ultimately treatment may be tapered or discontinued. In other cases, such as an untreated eyelid hemangioma, resultant amblyopia does not improve with involution of the cutaneous lesion. For these reasons, infants with infantile hemangiomas should be evaluated by an appropriate clinician during the early proliferative phase so that risk monitoring and treatment be individualized and outcomes can be optimized.
432: 460: 448: 420: 714:
hemangioma does not completely resolve. Residual redness may be noted and can be improved with laser therapy, most commonly PDL. Ablative fractional resurfacing may be considered for textural skin changes. Hemangiomas, especially those that have gotten very large during the growth phase, may leave behind stretched skin or fibrofatty tissue that may be disfiguring or require future surgical correction. Areas of prior ulceration may leave behind permanent scarring.
705:(PDL), plays a limited role in hemangioma management. PDL is most often used for treatment of ulcerated hemangiomas, often in conjunction with topical therapies and wound care, and may speed healing and diminish pain. Laser therapy may also be useful for early superficial IHs (although rapidly proliferating lesions may be more prone to ulceration following PDL treatment), and for the treatment of cutaneous telangiectasias which persist following involution. 60: 375: 579: 383: 394:, in premature children whose birth weight is less than 3 pounds (1.4 kg), in females, and in twin births. Early lesions may resemble a red scratch or patch, a white patch, or a bruise. The majority occur on the head and neck, but they can occur almost anywhere. The appearance and color of the IH depend on its location and depth within the level of the skin. 402:
which can present with yellow crusting, drainage, pain, or odor. Ulcerations are also at risk for bleeding, particularly deep lesions or in areas of friction. Multiple superficial hemangiomas, more than five, can be associated with extracutaneous hemangiomas, the most common being a liver (hepatic) hemangioma, and these infants warrant ultrasound examination.
518:. Large segmental hemangiomas over the lumbar spine can be associated with dysraphism, renal, and urogenital problems in association with a disorder called LUMBAR syndrome. Multiple cutaneous hemangiomas in infants may be an indicator for liver hemangiomas. Screening for liver involvement is often recommended in infants with five or more skin hemangiomas. 684:
to high injection pressures. Topical timolol maleate, a nonselective beta blocker available in a gel-forming solution approved for the treatment of glaucoma, has been increasingly recognized as a safe and effective off-label alternative for treatment of small hemangiomas. It is generally applied two to three times daily.
398:
skin, forming papules and confluent bright-red plaques like raised islands. Infantile hemangiomas have historically been referred to as β€œstrawberry marks" or "strawberry hemangiomas” in the past, as raised superficial hemangiomas can look like the side of a strawberry without seeds, and this remains a common lay term.
511:. The potential for psychological injury develops from school age onward. Considering treatment before school begins is, therefore, important if adequate spontaneous improvement has not occurred. Large IHs can leave visible skin changes secondary to severe stretching that results in altered surface texture. 683:
Intralesional corticosteroid (usually triamcinolone) injection has been used for small, localized hemangiomas, where it has been demonstrated to be relatively safe and effective. Injection of upper eyelid hemangiomas is controversial, given the reported risk of retinal embolization, possibly related
401:
Superficial IHs in certain locations, such as the posterior scalp, neck folds, and groin/perianal areas, are at potential risk of ulceration. Ulcerated hemangiomas can present as black crusted papules or plaques, or painful erosions or ulcers. Ulcerations are prone to secondary bacterial infections,
617:
Infantile hemangiomas in the liver are found in 16% of all liver hemangiomas. Its sizes are usually less than 1 to 2 cm in diameter. It may show a "flash-filling" phenomenon in which there is a fast enhancement of the contrast material in the lesion instead of slow, centripetal, nodular filling
722:
will require potentially ongoing neurologic, cardiac, and/or ophthalmologic monitoring. In cases of IHs that compromise of vital structures, symptoms may improve with involution of the hemangioma. For example, respiratory distress would improve with involution of a space-occupying IH involving the
666:
Other systemic therapies which may be effective for IH treatment include vincristine, interferon, and other agents with antiangiogenic properties. Vincristine, which requires central venous access for administration, is traditionally used as a chemotherapy agent, but has been demonstrated to have
626:
Most IHs disappear without treatment, leaving minimal to no visible marks. This may take many years, however, and a proportion of lesions may require some form of therapy. Multidisciplinary clinical practice guidelines for the management of infantile hemangiomas were recently published. Indications
604:
A precise history of the growth characteristics of the IH can be very helpful in making the diagnosis. In the first 4 to 8 weeks of life, IHs grow rapidly with primarily volumetric rather than radial growth. This is usually followed by a period of slower growth that can last 6–9 months, with 80% of
405:
Deep IHs present as poorly defined, bluish macules that can proliferate into papules, nodules, or larger tumors. Proliferating lesions are often compressible, but fairly firm. Many deep hemangiomas may have a few superficial capillaries visible evident over the primary deep component or surrounding
314:
In most cases no treatment is needed, other than close observation. Hemangiomas may grow rapidly, before stopping and slowly fading, with maximum improvement typically occurring by the age of 3.5 years. While this birthmark may be alarming in appearance, physicians generally counsel that it be left
409:
IHs are often classified as focal/localized, segmental, or indeterminate. Focal IHs appear localized to a specific location and appear to arise from a solitary spot. Segmental hemangiomas are larger, and appear to encompass a region of the body. Larger or segmental hemangiomas that span a large
397:
Superficial IHs are situated higher in the skin and have a bright red, erythematous to reddish-purple appearance. Superficial lesions can be flat and telangiectatic, composed of a macule or patch of small, varied branching, capillary blood vessels. They can also be raised and elevated from the
713:
In the involution phase, an IH finally begins to diminish in size. While IHs were previously thought to improve by about 10% each year, newer evidence suggests that maximal improvement and involution is typically reached by 3.5 years of age. Most IHs resolve by age 10, but in some patients, the
692:
Surgical excision of hemangiomas is rarely indicated, and limited to lesions which fail medical therapy (or when it is contraindicated), which are anatomically distributed in a location which is amenable to resection, and in which resection would likely be necessary and the scar will be similar
662:
Since that time, topical timolol maleate in addition to oral propranalol has become a common therapy for infantile hemangiomas. According to a 2018 Cochrane review, both of these therapies have demonstrated beneficial effects in terms of clearance of hemangiomas without an increase in harms. In
1677:
Horii KA, Drolet BA, Frieden IJ, Baselga E, Chamlin SL, Haggstrom AN, Holland KE, Mancini AJ, McCuaig CC, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Garzon MC (2011). "Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas".
506:
The most frequent complaints about IHs stem from psychosocial complications. The condition can affect a person's appearance and provoke attention and malicious reactions from others. Particular problems occur if the lip or nose is involved, as distortions can be difficult to treat
287:
on the skin. Typically, they begin during the first four weeks of life, growing until about five months of life, and then shrinking in size and disappearing over the next few years. Often skin changes remain after they shrink. Complications may include pain, bleeding,
2463:
Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ (September 2006). "Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment".
300:. It is the most common tumor of orbit and periorbital areas in childhood. It may occur in the skin, subcutaneous tissues and mucous membranes of oral cavities and lips as well as in extracutaneous locations including the liver and gastrointestinal tract. 647:, a nonselective beta blocker, is well tolerated and effective for treatment of hemangiomas, the agent was studied in a large, randomized, controlled trial and was approved by the U.S. Food and Drug Administration for this indication in 2014. Oral 960:
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, Annam A, Baker CN, Frommelt PC, Hodak A, Pate BM, Pelletier JL, Sandrock D, Weinberg ST, Whelan MA, SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE H (January 2019).
679:
2a and 2b, given by subcutaneous injection, has shown efficacy against hemangiomas, but may result in spastic diplegia in up to 20% of treated children. These agents are rarely used now in the era of beta-blocker therapy.
2235:
Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Nopper AJ, Frieden IJ (2008). "Growth characteristics of infantile hemangiomas: implications for management".
4332: 4312: 717:
Additional long-term sequelae stem from the identification of extracutaneous manifestations in association with the IH. For example, a patient with a large facial hemangioma who is found to meet criteria for
4003:
Brightman LA, Brauer JA, Terushkin V, Hunzeker C, Reddy KK, Weiss ET, Karen JK, Hale EK, Anolik R, Bernstein L, Geronemus RG (Nov 2012). "Ablative fractional resurfacing for involuted hemangioma residuum".
4133: 1676: 635:
Treatment options for IHs include medical therapies (systemic, intralesional, and topical), surgery, and laser therapy. Prior to 2008, the mainstay of therapy for problematic hemangiomas was oral
3372:
Egbert JE, Schwartz GS, Walsh AW (1996). "Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma".
4134:
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, Burrows P, Frieden IJ, Garzon MC, Lopez-Gutierrez JC, Lord DJ, Mitchel S, Powell J, Prendiville J, Vikkula M (Jul 2015).
4458: 693:
regardless of timing of the surgery. Surgery may also be useful for removal of residual fibrofatty tissue (following hemangioma involution) and reconstruction of damaged structures.
731:
The terminology used to define, describe, and categorize vascular tumors and malformations has changed over time. The term hemangioma was originally used to describe any vascular
3658:
Rizzo C, Brightman L, Chapas AM, et al. (2009). ""Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling " a retrospective chart analysis".
3323:
Ruttum MS, Abrams GW, Harris GJ, et al. (1993). "Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy".
1275: 2507:
Krowchuk D, Frieden I, Mancini A, Darrow D, Blei F, Greene A, Annam A, Baker C, Frommelt P, Hodak A, Pate B, Pelletier J, Sandrock D, Weinberg S, Whelan MA (January 2019).
890: 303:
The underlying reason for their occurrence is not clear. In about 10% of cases they appear to run in families. A few cases are associated with other abnormalities such as
2025:
Chiller KG, Passaro D, Frieden IJ (2002). "Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex".
315:
to disappear on its own, unless it is in the way of vision or blocking the nostrils. Certain cases, however, may result in problems and the use of medication such as
2234: 3142:
Wilson MW, Hoehn ME, Haik BG, Rieman M, Reiss U (2007). "Low-dose cyclophosphamide and interferon alfa 2a for the treatment of capillary hemangioma of the orbit".
1072: 1547:
Hunzeker C, Geronemus R (2010). Treatment of Superficial Infantile Hemangiomas of the Eyelid Using the 595-nm Pulsed Dye Laser". Dermatol. Surg. 36 (5): 590–597.
1462:
Haggstrom AN, Drolet BA, Baselga E, et al. (2007). ""Prospective study of infantile hemangiomas " demographic, prenatal, and perinatal characteristics".
4347: 4136:"Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. ISSVA Board and Scientific Committee" 1149:
Couto RA, Maclellan RA, Zurakowski D, Greene AK (2012). "Infantile hemangioma: clinical assessment of the involuting phase and implications for management".
4002: 4423: 618:
of the lesions in usual hemangiomas. On CT and MRI, it shows rapid filling during arterial phase, with contrast retention in venous and delayed phases.
4244:
Leon-Villapalos J, Wolfe K, Kangesu L (Apr 2005). "GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations".
3204:
Worle H, Maass E, Kohler B, et al. (1999). "Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication".
4279: 4230: 4175: 4039: 3989: 3897: 3848: 3799: 3750: 3715:
David LR, Malek MM, Argenta LC (2003). "Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients".
3701: 3562: 3464: 3407: 3358: 3296: 3247: 3177: 3128: 3079: 3024: 2907: 2831: 2698: 2643: 2594: 2384: 2279: 2170: 2068: 1959: 1904: 1849: 1776: 1721: 1663: 1608: 1497: 1445: 1192: 431: 3261:
Chen MT, Yeong EK, Horng SY (2000). "Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases".
3813:
Garden JM, Bakus AD, Paller AS (1992). "Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis".
413:
Unless ulceration occurs, an IH does not tend to bleed and is not painful. Discomfort may arise if it is bulky and blocks a vital orifice.
4465: 4513: 3190:
Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy.
2135:
North PE, Waner M, Mizeracki A, Mihm MC Jr (Jan 2000). "GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas".
3093:
Enjolras O, Breviere GM, Roger G, et al. (2004). "Vincristine treatment for function- and life-threatening infantile hemangioma".
2747:
Greene AK, Couto RA (2011). "Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol".
410:
area can sometimes have underlying anomalies that may require investigation, especially when located on the face, sacrum, or pelvis.
346:
babies. They can occur anywhere on the body, though 83% occur on the head or neck area. The word "hemangioma" comes from the Greek
4846: 491:
can be compromised. If located near the eye, a growing hemangioma may cause an occlusion or deviation of the eye that can lead to
4851: 419: 1511: 542:
embolizes to the fetal dermis during gestation, resulting in hemangiomagenesis. However, another group of researchers conducted
2341:
Erhardt CA, Vesoulis Z, Kashkari S (2000). "Fine needle aspiration cytology of cellular hemangioma of infancy. A case report".
3954:
Stier MF, Glick SA, Hirsch RJ (Feb 2008). "Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas".
2402: 1920:""(November 2006). "No evidence for maternal-fetal microchimerism in infantile hemangioma: a molecular genetic investigation" 1332: 1250: 1014: 1737:""(December 2007). "Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma" 2974: 17: 447: 3515:"Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective multicenter cohort study" 1076: 2397:
Kumar Vinay: Robbins and Coltran pathologic basis of disease 8ed.. pp. 520-521 Philadelphia: Saunders Elsevier, 2010.
4813: 3862:
Waner M, Suen JY, Dinehart S, et al. (1994). "Laser photocoagulation of superficial proliferating hemangiomas".
1039: 53:
Infantile haemangioma, hemangioma, capillary hemangioma, capillary angioma, strawberry haemangioma, strawberry mark
4555: 386:
Infantile hemangioma, well-circumscribed red, violet, exophytic vascular tumor on the nose of a one-year-old child
4682: 2608:
Kim HJ, Colombo M, Frieden IJ (2001). "Ulcerated hemangiomas: clinical characteristics and response to therapy".
1302: 668: 187: 3421:
Moehrle M, Leaute-Labreze C, Schmidt V, et al. (2013). "Topical timolol for small hemangiomas of infancy".
2298:
North PE, Mihm MC Jr (2001). "Histopathological diagnosis of infantile hemangiomas and vascular malformations".
659:. Propranolol has subsequently become the first-line systemic medical therapy for treatment of these lesions. 547: 85: 3764:
Morelli JG, Tan OT, Weston WL (1991). "Treatment of ulcerated hemangiomas with the pulsed tunable dye laser".
2921: 459: 3478:
Guo S, Ni N (2010). "Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution".
4191:"Jr. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma" 3309:
Chantharatanapiboon W. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.
749: 390:
Infantile hemangiomas typically develop in the first few weeks or months of life. They are more common in
4856: 4704: 4451: 2414:
Thampy R, Elsayes KM, Menias CO, Pickhardt PJ, Kang HC, Deshmukh SP, Ahmed K, Korivi BR (November 2017).
1298: 4775: 598: 4841: 4428: 916: 2975:
Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo-Hernandez H, Arevalo-Rodriguez I (2018).
2934:
Chinnadurai S, Fonnesbeck C, Snyder KM, Sathe NA, Morad A, Likis FE, McPheeters ML (February 2016).
1055: 4358: 2844:
Hogeling M et al. (2011) "A randomized controlled trial of propranolol for infantile hemangiomas".
526:
The cause of hemangioma is currently unknown, but several studies have suggested the importance of
589:
The majority of IHs can be diagnosed by history and physical examination. In rare cases, imaging (
105: 2659:""Oral corticosteroid use is effective for cutaneous hemangiomas " an evidence-based evaluation" 4607: 2712:
Sadan N, Wolach B (1996). "Treatment of hemangiomas of infants with high doses of prednisone".
174: 4398: 643:
therapy is contraindicated or poorly tolerated. Following the serendipitous observation that
4786: 4726: 4569: 4273: 4224: 4188: 4169: 4033: 3983: 3891: 3842: 3793: 3744: 3695: 3556: 3458: 3401: 3352: 3290: 3241: 3171: 3122: 3073: 3018: 2901: 2825: 2692: 2637: 2588: 2378: 2273: 2164: 2062: 1953: 1898: 1843: 1770: 1715: 1657: 1602: 1491: 1439: 1322: 1186: 179: 499:
due to the amount of blood that must be pumped to excess blood vessels. Lesions adjacent to
475:
Almost no IHs are associated with complications. They may break down on the surface, called
4642: 1803: 479:, which can be painful and problematic. If the ulceration is deep, significant discomfort, 1525: 514:
Large segmental hemangiomas of the head and neck can be associated with a disorder called
334:
in babies, occurring in about 5-10% of all births. They occur more frequently in females,
8: 4658: 4336: 3777: 289: 195: 111: 1807: 4653: 4518: 4352: 4341: 4078: 3936: 3875: 3683: 3544: 3446: 3229: 3001: 2976: 2889: 2772: 2489: 2440: 2415: 2366: 2323: 2261: 2112: 2087:
Dubois J, Alison M (Jun 2010). "Vascular anomalies: what a radiologist needs to know".
2050: 1999: 1974: 1826: 1791: 1703: 1585: 1558: 1376: 1349: 1174: 1123: 594: 570: 183: 92: 33: 3826: 3728: 3385: 3274: 2725: 2311: 2148: 1881: 1864: 554:
which contradicted this hypothesis. Other studies have revealed the role of increased
4794: 4369: 4261: 4212: 4157: 4113: 4109: 4070: 4021: 3971: 3940: 3928: 3879: 3830: 3781: 3732: 3675: 3671: 3640: 3599: 3536: 3531: 3514: 3495: 3438: 3434: 3389: 3340: 3278: 3221: 3159: 3110: 3061: 3037: 3006: 2957: 2893: 2881: 2813: 2764: 2729: 2680: 2625: 2576: 2530: 2481: 2445: 2398: 2358: 2315: 2253: 2210: 2152: 2104: 2042: 2004: 1941: 1886: 1831: 1758: 1695: 1691: 1645: 1590: 1479: 1427: 1381: 1328: 1246: 1223: 1166: 1128: 1035: 1010: 984: 837: 534:
coupled with increased circulating estrogen after birth may be the stimulus. Also, a
531: 164: 72: 4096:
Mulliken JB, Glowacki J (Jul 1982). "Classification of pediatric vascular lesions".
3687: 3548: 3491: 3450: 3233: 2776: 2493: 2327: 2189:"Infantile hemangiomas with minimal or arrested growth: A retrospective case series" 2116: 1707: 1178: 4474: 4409: 4253: 4202: 4147: 4105: 4082: 4062: 4017: 4013: 3963: 3920: 3871: 3822: 3773: 3724: 3667: 3630: 3589: 3526: 3487: 3430: 3381: 3332: 3270: 3213: 3151: 3102: 3051: 2996: 2992: 2988: 2947: 2871: 2803: 2756: 2721: 2670: 2617: 2566: 2520: 2473: 2435: 2427: 2370: 2350: 2307: 2265: 2245: 2200: 2144: 2096: 2034: 1994: 1986: 1931: 1876: 1821: 1811: 1748: 1687: 1635: 1580: 1570: 1471: 1419: 1371: 1361: 1215: 1158: 1118: 1110: 974: 827: 702: 676: 543: 343: 260: 199: 156: 81: 3336: 2205: 2188: 2054: 1538:
Oakley, Amanda. "Infantile haemangioma.". DermNet NZ. Retrieved February 11, 2013.
4805: 4594: 4363: 4207: 4190: 3594: 3577: 3155: 3106: 2789: 2760: 2038: 1640: 1623: 1162: 636: 515: 320: 308: 227: 152: 3056: 3039: 2675: 2658: 1792:"Evidence by molecular profiling for a placental origin of infantile hemangioma" 1475: 1423: 4534: 4505: 4482: 4374: 4257: 3967: 3141: 2857: 1753: 1736: 1148: 719: 672: 656: 559: 391: 324: 304: 256: 191: 4321: 3635: 3618: 2100: 4835: 496: 366: 339: 297: 293: 119: 115: 2860:"A randomized, controlled trial of oral propranolol in infantile hemangioma" 2621: 1816: 1348:
Sand M, Sand D, Thrandorf C, Paech V, Altmeyer P, Bechara FG (4 June 2010).
862: 307:. Diagnosis is generally based on the symptoms and appearance. Occasionally 4550: 4265: 4216: 4161: 4152: 4135: 4074: 4025: 3975: 3736: 3679: 3644: 3603: 3540: 3512: 3499: 3442: 3282: 3225: 3163: 3114: 3010: 2961: 2952: 2935: 2885: 2817: 2768: 2684: 2629: 2580: 2571: 2554: 2534: 2525: 2508: 2485: 2477: 2449: 2362: 2319: 2257: 2249: 2214: 2156: 2108: 2046: 2008: 1945: 1936: 1919: 1890: 1835: 1762: 1699: 1649: 1594: 1483: 1431: 1385: 1271: 1170: 1132: 1114: 988: 979: 962: 841: 832: 815: 640: 583: 555: 331: 27:
Raised red skin lesion that affects infants caused by benign vascular tumor
4304: 4189:
North PE, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC (Dec 2001).
4117: 3932: 3883: 3834: 3785: 3393: 3344: 3217: 3065: 2922:
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205410s000lbl.pdf
2876: 2859: 2733: 2134: 1366: 1227: 667:
efficacy against hemangiomas and other childhood vascular tumors, such as
4393: 4066: 3924: 2808: 2791: 2509:"Clinical Practice Guideline for the Management of Infantile Hemangiomas" 2431: 2416:"Imaging features of rare mesenychmal liver tumours: beyond haemangiomas" 1219: 1098: 963:"Clinical Practice Guideline for the Management of Infantile Hemangiomas" 648: 644: 316: 219: 142: 77: 59: 4433: 2936:"Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis" 2790:
Leaute-Labreze C, Dumas, de la Roque E, Hubiche T, et al. (2008).
1575: 744: 590: 535: 508: 476: 374: 214: 3420: 3040:"Treatment of life-threatening infantile hemangiomas with vincristine" 2354: 1990: 578: 382: 4443: 4404: 4243: 2858:
Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, et al. (2015).
1410:
Drolet BA, Esterly NB, Frieden IJ (1999). "Hemangiomas in Children".
492: 488: 2656: 1734: 539: 527: 480: 2340: 1917: 1735:
Kleinman ME, Greives MR, Churgin SS, et al. (December 2007).
1461: 3513:
Chakkittakandiyii A, Phillips R, Frieden IJ, et al. (2012).
2024: 1918:
Pittman KM, Losken HW, Kleinman ME, et al. (November 2006).
1409: 652: 495:. Very rarely, extremely large hemangiomas can cause high-output 223: 3371: 3092: 2933: 2552: 639:, which are effective and remain an option for patients in whom 4316: 3657: 3322: 1789: 484: 335: 284: 148: 98: 4053:
Bruckner AL, Frieden IJ (Apr 2003). "Hemangiomas of infancy".
3812: 3714: 3578:"Topical timolol gel for infantile hemangiomas: a pilot study" 3038:
Perez Payarols J, Pardo Masferrer J, Gomez Bellvert C (1995).
1621: 3953: 3763: 2607: 2462: 1862: 1559:"PHACES association: a neuroradiologic review of 17 patients" 732: 438: 3861: 2506: 2413: 1556: 959: 814:
Darrow DH, Greene AK, Mancini AJ, Nopper AJ (October 2015).
4438: 4325: 3575: 3260: 500: 3203: 2657:
Bennett ML, Fleischer AB, Chamlin SL, et al. (2001).
483:
and infection may occur. If a hemangioma develops in the
1004: 813: 606: 551: 1972: 1512:"GI Associated Hemangiomas & Vascular Malformations" 1067: 1065: 425:
Hemangioma on forehead showing signs of early regression
4424:
Infantile Hemangiomas: About Strawberry Baby Birthmarks
4095: 4052: 2977:"Interventions for infantile haemangiomas of the skin" 2553:
Darrow DH, Greene AK, Mancini AJ, et al. (2015).
1347: 1099:"Infantile hemangioma: Timely diagnosis and treatment" 1056:"What is Infantile Hemangioma (Strawberry Birthmark)?" 3619:"Management of hemangiomas and other vascular tumors" 1790:
BarnΓ©s CM, Huang S, Kaipainen A, et al. (2005).
1062: 4791:
Limb CM + congenital non-progressive limb overgrowth
4294: 3910: 2297: 1622:
Heyer GL, Dowling MM, Licht DJ, et al. (2008).
1245:(11th ed.). Lippincott Williams & Wilkins. 1075:. Parenting and Child Health website. Archived from 2746: 1032:
Andrews' Diseases of the Skin: Clinical Dermatology
530:signaling in proliferation. Localized soft-tissue 2555:"Diagnosis and management of infantile hemangioma" 2186: 2086: 1557:Oza VS, Wang E, Berenstein A, et al. (2008). 816:"Diagnosis and Management of Infantile Hemangioma" 2711: 1029: 4833: 3864:The Journal of Dermatologic Surgery and Oncology 1865:"Are infantile hemangiomas of placental origin?" 1457: 1455: 1266: 1264: 1262: 4595:Cutaneous and/or mucosal CM ("port-wine" stain) 2927: 2792:"Propranolol for severe hemangiomas of infancy" 1966: 2020: 2018: 1624:"The cerebral vasculopathy of PHACES syndrome" 550:in hemangioma tissue compared to the mother's 4459: 4129: 4127: 2548: 2546: 2544: 2456: 2082: 2080: 2078: 1452: 1405: 1403: 1401: 1399: 1397: 1395: 1259: 453:Hemangioma of the liver as seen on ultrasound 4498:Infantile hemangioma / Hemangioma of infancy 4278:: CS1 maint: multiple names: authors list ( 4229:: CS1 maint: multiple names: authors list ( 4174:: CS1 maint: multiple names: authors list ( 4089: 4038:: CS1 maint: multiple names: authors list ( 3988:: CS1 maint: multiple names: authors list ( 3911:Wahrman JE, Honig PJ (1994). "Hemangiomas". 3896:: CS1 maint: multiple names: authors list ( 3847:: CS1 maint: multiple names: authors list ( 3798:: CS1 maint: multiple names: authors list ( 3749:: CS1 maint: multiple names: authors list ( 3700:: CS1 maint: multiple names: authors list ( 3561:: CS1 maint: multiple names: authors list ( 3463:: CS1 maint: multiple names: authors list ( 3406:: CS1 maint: multiple names: authors list ( 3357:: CS1 maint: multiple names: authors list ( 3295:: CS1 maint: multiple names: authors list ( 3246:: CS1 maint: multiple names: authors list ( 3176:: CS1 maint: multiple names: authors list ( 3127:: CS1 maint: multiple names: authors list ( 3078:: CS1 maint: multiple names: authors list ( 3023:: CS1 maint: multiple names: authors list ( 2920:United States Food and Drug Administration. 2906:: CS1 maint: multiple names: authors list ( 2830:: CS1 maint: multiple names: authors list ( 2697:: CS1 maint: multiple names: authors list ( 2642:: CS1 maint: multiple names: authors list ( 2593:: CS1 maint: multiple names: authors list ( 2383:: CS1 maint: multiple names: authors list ( 2293: 2291: 2289: 2278:: CS1 maint: multiple names: authors list ( 2230: 2228: 2226: 2224: 2169:: CS1 maint: multiple names: authors list ( 2130: 2128: 2126: 2067:: CS1 maint: multiple names: authors list ( 1958:: CS1 maint: multiple names: authors list ( 1903:: CS1 maint: multiple names: authors list ( 1848:: CS1 maint: multiple names: authors list ( 1775:: CS1 maint: multiple names: authors list ( 1728: 1720:: CS1 maint: multiple names: authors list ( 1662:: CS1 maint: multiple names: authors list ( 1607:: CS1 maint: multiple names: authors list ( 1541: 1496:: CS1 maint: multiple names: authors list ( 1444:: CS1 maint: multiple names: authors list ( 1191:: CS1 maint: multiple names: authors list ( 1144: 1142: 917:"ISSVA Classification of Vascular Anomalies" 655:, observation without intervention, or oral 4693:Familial intraosseous vascular malformation 4182: 3477: 2650: 2334: 2015: 1911: 538:was presented by researchers that maternal 4466: 4452: 4429:ISSVA Classification of Vascular Anomalies 4124: 2851: 2783: 2740: 2541: 2182: 2180: 2075: 1783: 1392: 1293: 1291: 1000: 998: 809: 807: 805: 803: 801: 799: 797: 795: 793: 791: 789: 787: 785: 441:of a 2-year-old child, in the "rest stage" 58: 4206: 4151: 3634: 3616: 3593: 3530: 3055: 3000: 2951: 2875: 2807: 2705: 2674: 2570: 2524: 2439: 2391: 2286: 2221: 2204: 2123: 1998: 1935: 1880: 1856: 1825: 1815: 1752: 1670: 1639: 1615: 1584: 1574: 1375: 1365: 1139: 1122: 1005:Ronald P R, Jean L B, Joseph L J (2007). 978: 885: 883: 831: 783: 781: 779: 777: 775: 773: 771: 769: 767: 765: 323:are recommended. Occasionally surgery or 263:that affects babies. Other names include 4650:β€œAcquired” progressive lymphatic anomaly 4237: 955: 953: 951: 949: 947: 945: 943: 941: 908: 577: 569: 381: 373: 365: 2981:Cochrane Database of Systematic Reviews 2601: 2177: 1550: 1288: 1234: 1205: 995: 255:due to appearance, is a type of benign 14: 4834: 4473: 1975:"Pathogenesis of Infantile Hemangioma" 1863:North PE, Waner M, Brodsky MC (2002). 1240: 1023: 880: 762: 283:. They appear as a red or blue raised 4447: 1973:Greenberger SA, Bischoff (Jul 2013). 938: 857: 855: 853: 851: 361: 4761:Capillary-arteriovenous malformation 3778:10.1001/archpedi.1991.02160090114036 3576:Pope E, Chakkittakandiyil A (2010). 1103:Clinical and Experimental Pediatrics 1096: 1030:James W, Berger T, Elston D (2005). 914: 24: 3876:10.1111/j.1524-4725.1994.tb03748.x 1206:Wahrman JE (1994). "Hemangiomas". 895:Merck Manuals Professional Edition 848: 25: 4868: 4814:Bannayan-Riley-Ruvalcaba syndrome 4290: 562:in the etiology of hemangiomas. 4556:Epithelioid hemangioendothelioma 4528:Locally aggressive or borderline 4110:10.1097/00006534-198207000-00041 3672:10.1111/j.1524-4725.2009.01356.x 3532:10.1111/j.1525-1470.2011.01664.x 3435:10.1111/j.1525-1470.2012.01723.x 2420:The British Journal of Radiology 1741:Arterioscler. Thromb. Vasc. Biol 1692:10.1111/j.1525-1470.2011.01420.x 470: 465:A liver hemangioma as seen on CT 458: 446: 430: 418: 354:(αΌ€Ξ³Ξ³Ξ΅αΏ–ΞΏΞ½) meaning "vessel"; and 169:Based on symptoms and appearance 4847:Dermal and subcutaneous growths 4799:Macrocephaly - CM (M-CM / MCAP) 4769:Associated with other anomalies 4690:Cerebral cavernous malformation 4683:Blue rubber bleb nevus syndrome 4535:Kaposiform hemangioendothelioma 4046: 3996: 3947: 3904: 3855: 3806: 3757: 3708: 3651: 3610: 3569: 3506: 3492:10.1001/archophthalmol.2009.370 3471: 3414: 3365: 3325:J Pediatr Ophthalmol Strabismus 3316: 3303: 3254: 3197: 3184: 3135: 3086: 3031: 2968: 2914: 2838: 2500: 2407: 2300:Facial Plast Surg Clin North Am 2187:Suh KY, Frieden IJ (Sep 2010). 1532: 1518: 1504: 1412:New England Journal of Medicine 1350:"Cutaneous lesions of the nose" 1341: 1327:. CRC Press. 1999. p. 16. 1315: 1303:American Academy of Dermatology 1199: 1090: 669:kaposiform hemangioendothelioma 503:may cause erosion of the bone. 188:kaposiform hemangioendothelioma 4852:Cutaneous congenital anomalies 4633:Generalized lymphatic anomaly 4439:Vascular Birthmarks Foundation 4018:10.1001/archdermatol.2012.2346 2993:10.1002/14651858.CD006545.pub3 1979:British Journal of Dermatology 1048: 726: 701:Laser therapy, most often the 548:single-nucleotide polymorphism 86:Oral and Maxillofacial Surgery 13: 1: 4758:Lymphatic-venous malformation 4696:Verrucous venous malformation 4434:Hemangioma Investigator Group 3827:10.1016/s0022-3476(05)82481-3 3729:10.1016/s0007-1226(03)00152-8 3386:10.1016/s0002-9394(14)70629-4 3337:10.3928/0191-3913-19930101-03 3275:10.1016/s0022-3468(00)90205-7 2726:10.1016/s0022-3476(96)70446-8 2312:10.1016/S1064-7406(23)00480-7 2206:10.1001/archdermatol.2010.197 2149:10.1016/s0046-8177(00)80192-6 1882:10.1016/S0161-6420(02)01071-0 1324:Lexicon Orthopaedic Etymology 1276:Vascular Birthmark Foundation 755: 630: 330:It is one of the most common 311:can assist in the diagnosis. 209:Close observation, medication 67:A small hemangioma of infancy 4636:Kaposiform lymphangiomatosis 4612:Incorrect name: Lymphangioma 4608:Lymphatic malformations (LM) 4208:10.1001/archderm.137.12.1607 3595:10.1001/archdermatol.2010.67 3156:10.1016/j.ophtha.2006.11.031 3107:10.1016/j.arcped.2003.10.014 2761:10.1097/prs.0b013e3182221398 2039:10.1001/archderm.138.12.1567 1796:Proc. Natl. Acad. Sci. U.S.A 1641:10.1161/strokeaha.107.485185 1243:Langman's Medical Embryology 1163:10.1097/prs.0b013e31825dc129 750:List of cutaneous conditions 708: 621: 565: 7: 4783:Servelle-Martorell syndrome 4705:Arteriovenous malformations 4679:Familial VM cutaneo-mucosal 3057:10.1056/nejm199507063330120 2676:10.1001/archderm.137.9.1208 1476:10.1016/j.jpeds.2006.12.003 1424:10.1056/nejm199907153410307 1034:(10th ed.). Saunders. 738: 370:A flat hemangioma in a baby 10: 4873: 4802:Microcephaly - CM (MICCAP) 4776:Klippel-Trenaunay syndrome 4258:10.1016/j.bjps.2004.05.029 3968:10.1016/j.jaad.2007.10.492 1754:10.1161/ATVBAHA.107.150284 687: 599:magnetic resonance imaging 279:. and formerly known as a 31: 4768: 4751: 4725: 4703: 4669: 4606: 4584: 4577: 4568: 4543: 4527: 4490: 4481: 4384: 4298: 3636:10.1016/j.cps.2010.08.001 2101:10.1007/s00247-010-1621-y 1526:"Hemangiomas (Infantile)" 1007:Dermatology: 2-Volume Set 521: 233: 213: 205: 173: 163: 141: 133: 125: 104: 91: 71: 66: 57: 49: 44: 4687:Glomuvenous malformation 3194:1998;132(3 pt 1):527-30. 1354:Head & Face Medicine 1272:"Hemangioma Information" 924:ISSVA Classification pdf 696: 612: 358:(-ωμα) meaning "tumor". 350:(Ξ±αΌ·ΞΌΞ±) meaning "blood"; 137:Superficial, deep, mixed 32:Not to be confused with 4585:Capillary malformations 4510:Spindle-cell hemangioma 3313:2008;91(suppl 3):S90-6. 2622:10.1067/mjd.2001.112382 1817:10.1073/pnas.0509579102 891:"Infantile Hemangiomas" 651:is more effective than 4570:Vascular malformations 4514:Epithelioid hemangioma 4153:10.1542/peds.2014-3673 2953:10.1542/peds.2015-3896 2572:10.1542/peds.2015-2485 2526:10.1542/peds.2018-3475 2478:10.1542/peds.2006-0413 2250:10.1542/peds.2007-2767 1937:10.1038/sj.jid.5700516 1115:10.3345/cep.2021.00752 980:10.1542/peds.2018-3475 833:10.1542/peds.2015-2485 586: 575: 387: 379: 378:A resolving hemangioma 371: 251:), sometimes called a 175:Differential diagnosis 4787:Sturge-Weber syndrome 4780:Parkes Weber Syndrome 4727:Arteriovenous fistula 4659:Nonne-Milroy syndrome 4502:Congenital hemangioma 3218:10.1007/s004310051089 2877:10.1056/NEJMoa1404710 1563:AJNR Am J Neuroradiol 1367:10.1186/1746-160X-6-7 581: 573: 385: 377: 369: 269:strawberry hemangioma 180:Congenital hemangioma 129:First 4 weeks of life 4670:Venous malformations 4643:Gorham-Stout disease 4067:10.1067/mjd.2003.200 3925:10.1542/pir.15-7-266 2809:10.1056/nejmc0708819 2432:10.1259/bjr.20170373 1220:10.1542/pir.15-7-266 1009:. St. Louis: Mosby. 574:Capillary hemangioma 281:cavernous hemangioma 273:strawberry birthmark 265:capillary hemangioma 245:infantile hemangioma 45:Infantile hemangioma 18:Capillary hemangioma 4619:Common (cystic) LM 4098:Plast Reconstr Surg 2924:; accessed 9/29/15. 2848:128 (2): e259–e266. 2749:Plast Reconstr Surg 1924:J. Invest. Dermatol 1808:2005PNAS..10219097B 1151:Plast Reconstr Surg 582:Strawberry naevus, 196:venous malformation 97:Raised red or blue 4857:Vascular anomalies 4654:Primary lymphedema 4519:Pyogenic granuloma 4475:Vascular anomalies 4385:External resources 4055:J Am Acad Dermatol 3956:J Am Acad Dermatol 3617:Greene AK (2011). 2610:J Am Acad Dermatol 2426:(1079): 20170373. 1576:10.3174/ajnr.a0937 1241:Sadler TW (2009). 587: 576: 437:Hemangioma on the 388: 380: 372: 362:Signs and symptoms 184:pyogenic granuloma 34:Hepatic hemangioma 4829: 4828: 4825: 4824: 4795:Maffucci syndrome 4747: 4746: 4564: 4563: 4419: 4418: 2565:(4): e1060–1104. 2403:978-0-8089-2402-9 2355:10.1159/000328604 2033:(12): 1567–1576. 1991:10.1111/bjd.12435 1802:(52): 19097–102. 1334:978-90-5702-597-6 1252:978-1-60547-656-8 1016:978-1-4160-2999-1 241: 240: 165:Diagnostic method 39:Medical condition 16:(Redirected from 4864: 4842:Benign neoplasms 4810:Proteus syndrome 4613: 4582: 4581: 4575: 4574: 4488: 4487: 4468: 4461: 4454: 4445: 4444: 4296: 4295: 4284: 4283: 4277: 4269: 4241: 4235: 4234: 4228: 4220: 4210: 4186: 4180: 4179: 4173: 4165: 4155: 4131: 4122: 4121: 4093: 4087: 4086: 4050: 4044: 4043: 4037: 4029: 4000: 3994: 3993: 3987: 3979: 3951: 3945: 3944: 3908: 3902: 3901: 3895: 3887: 3859: 3853: 3852: 3846: 3838: 3810: 3804: 3803: 3797: 3789: 3761: 3755: 3754: 3748: 3740: 3712: 3706: 3705: 3699: 3691: 3655: 3649: 3648: 3638: 3614: 3608: 3607: 3597: 3573: 3567: 3566: 3560: 3552: 3534: 3519:Pediatr Dermatol 3510: 3504: 3503: 3480:Arch. Ophthalmol 3475: 3469: 3468: 3462: 3454: 3423:Pediatr Dermatol 3418: 3412: 3411: 3405: 3397: 3369: 3363: 3362: 3356: 3348: 3320: 3314: 3311:J Med Assoc Thai 3307: 3301: 3300: 3294: 3286: 3258: 3252: 3251: 3245: 3237: 3201: 3195: 3188: 3182: 3181: 3175: 3167: 3139: 3133: 3132: 3126: 3118: 3090: 3084: 3083: 3077: 3069: 3059: 3035: 3029: 3028: 3022: 3014: 3004: 2972: 2966: 2965: 2955: 2946:(2): e20153896. 2931: 2925: 2918: 2912: 2911: 2905: 2897: 2879: 2855: 2849: 2842: 2836: 2835: 2829: 2821: 2811: 2787: 2781: 2780: 2744: 2738: 2737: 2709: 2703: 2702: 2696: 2688: 2678: 2654: 2648: 2647: 2641: 2633: 2605: 2599: 2598: 2592: 2584: 2574: 2550: 2539: 2538: 2528: 2519:(1): e20183475. 2504: 2498: 2497: 2460: 2454: 2453: 2443: 2411: 2405: 2395: 2389: 2388: 2382: 2374: 2338: 2332: 2331: 2295: 2284: 2283: 2277: 2269: 2232: 2219: 2218: 2208: 2184: 2175: 2174: 2168: 2160: 2132: 2121: 2120: 2084: 2073: 2072: 2066: 2058: 2022: 2013: 2012: 2002: 1970: 1964: 1963: 1957: 1949: 1939: 1915: 1909: 1908: 1902: 1894: 1884: 1860: 1854: 1853: 1847: 1839: 1829: 1819: 1787: 1781: 1780: 1774: 1766: 1756: 1732: 1726: 1725: 1719: 1711: 1680:Pediatr Dermatol 1674: 1668: 1667: 1661: 1653: 1643: 1619: 1613: 1612: 1606: 1598: 1588: 1578: 1554: 1548: 1545: 1539: 1536: 1530: 1529: 1522: 1516: 1515: 1508: 1502: 1501: 1495: 1487: 1459: 1450: 1449: 1443: 1435: 1407: 1390: 1389: 1379: 1369: 1345: 1339: 1338: 1319: 1313: 1312: 1310: 1309: 1295: 1286: 1285: 1283: 1282: 1268: 1257: 1256: 1238: 1232: 1231: 1203: 1197: 1196: 1190: 1182: 1146: 1137: 1136: 1126: 1094: 1088: 1087: 1085: 1084: 1069: 1060: 1059: 1052: 1046: 1045: 1027: 1021: 1020: 1002: 993: 992: 982: 973:(1): e20183475. 957: 936: 935: 933: 931: 921: 912: 906: 905: 903: 901: 887: 878: 877: 875: 874: 863:"Birthmarks NHS" 859: 846: 845: 835: 826:(4): e1060-104. 811: 703:pulsed dye laser 677:Interferon-alpha 544:genetic analyses 462: 450: 434: 422: 344:low birth weight 340:prematurely born 277:strawberry nevus 200:vascular anomaly 157:low birth weight 110:Pain, bleeding, 82:gastroenterology 62: 42: 41: 21: 4872: 4871: 4867: 4866: 4865: 4863: 4862: 4861: 4832: 4831: 4830: 4821: 4806:CLOVES syndrome 4764: 4743: 4721: 4699: 4665: 4647:Channel type LM 4628:Mixed cystic LM 4611: 4610: 4602: 4560: 4539: 4523: 4483:Vascular tumors 4477: 4472: 4420: 4415: 4414: 4380: 4379: 4307: 4293: 4288: 4287: 4271: 4270: 4246:Br J Plast Surg 4242: 4238: 4222: 4221: 4201:(12): 1607–20. 4187: 4183: 4167: 4166: 4132: 4125: 4094: 4090: 4051: 4047: 4031: 4030: 4001: 3997: 3981: 3980: 3952: 3948: 3909: 3905: 3889: 3888: 3860: 3856: 3840: 3839: 3811: 3807: 3791: 3790: 3762: 3758: 3742: 3741: 3717:Br J Plast Surg 3713: 3709: 3693: 3692: 3666:(12): 1947–54. 3656: 3652: 3623:Clin Plast Surg 3615: 3611: 3574: 3570: 3554: 3553: 3511: 3507: 3476: 3472: 3456: 3455: 3419: 3415: 3399: 3398: 3374:Am J Ophthalmol 3370: 3366: 3350: 3349: 3321: 3317: 3308: 3304: 3288: 3287: 3259: 3255: 3239: 3238: 3202: 3198: 3189: 3185: 3169: 3168: 3140: 3136: 3120: 3119: 3091: 3087: 3071: 3070: 3036: 3032: 3016: 3015: 2987:(4): CD006545. 2973: 2969: 2932: 2928: 2919: 2915: 2899: 2898: 2856: 2852: 2843: 2839: 2823: 2822: 2802:(24): 2649–51. 2788: 2784: 2745: 2741: 2710: 2706: 2690: 2689: 2655: 2651: 2635: 2634: 2606: 2602: 2586: 2585: 2551: 2542: 2505: 2501: 2461: 2457: 2412: 2408: 2396: 2392: 2376: 2375: 2339: 2335: 2296: 2287: 2271: 2270: 2233: 2222: 2185: 2178: 2162: 2161: 2133: 2124: 2085: 2076: 2060: 2059: 2023: 2016: 1971: 1967: 1951: 1950: 1916: 1912: 1896: 1895: 1861: 1857: 1841: 1840: 1788: 1784: 1768: 1767: 1747:(12): 2664–70. 1733: 1729: 1713: 1712: 1675: 1671: 1655: 1654: 1620: 1616: 1600: 1599: 1555: 1551: 1546: 1542: 1537: 1533: 1524: 1523: 1519: 1510: 1509: 1505: 1489: 1488: 1460: 1453: 1437: 1436: 1408: 1393: 1346: 1342: 1335: 1321: 1320: 1316: 1307: 1305: 1297: 1296: 1289: 1280: 1278: 1270: 1269: 1260: 1253: 1239: 1235: 1204: 1200: 1184: 1183: 1147: 1140: 1109:(11): 573–574. 1097:Park M (2021). 1095: 1091: 1082: 1080: 1071: 1070: 1063: 1054: 1053: 1049: 1042: 1028: 1024: 1017: 1003: 996: 958: 939: 929: 927: 919: 913: 909: 899: 897: 889: 888: 881: 872: 870: 861: 860: 849: 812: 763: 758: 741: 729: 711: 699: 690: 657:corticosteroids 637:corticosteroids 633: 624: 615: 568: 524: 516:PHACES syndrome 473: 466: 463: 454: 451: 442: 435: 426: 423: 364: 325:laser treatment 309:medical imaging 253:strawberry mark 153:premature birth 40: 37: 28: 23: 22: 15: 12: 11: 5: 4870: 4860: 4859: 4854: 4849: 4844: 4827: 4826: 4823: 4822: 4820: 4819: 4818:CLAPO syndrome 4816: 4811: 4808: 4803: 4800: 4797: 4792: 4789: 4784: 4781: 4778: 4772: 4770: 4766: 4765: 4763: 4762: 4759: 4755: 4753: 4749: 4748: 4745: 4744: 4742: 4741: 4738: 4735: 4731: 4729: 4723: 4722: 4720: 4719: 4716: 4713: 4709: 4707: 4701: 4700: 4698: 4697: 4694: 4691: 4688: 4685: 4680: 4677: 4673: 4671: 4667: 4666: 4664: 4663: 4662: 4661: 4651: 4648: 4645: 4639: 4638: 4637: 4631: 4630: 4629: 4626: 4625:Microcystic LM 4623: 4622:Macrocystic LM 4616: 4614: 4604: 4603: 4601: 4600: 4597: 4592: 4588: 4586: 4579: 4572: 4566: 4565: 4562: 4561: 4559: 4558: 4553: 4547: 4545: 4541: 4540: 4538: 4537: 4531: 4529: 4525: 4524: 4522: 4521: 4516: 4511: 4508: 4506:Tufted angioma 4503: 4500: 4494: 4492: 4485: 4479: 4478: 4471: 4470: 4463: 4456: 4448: 4442: 4441: 4436: 4431: 4426: 4417: 4416: 4413: 4412: 4401: 4389: 4388: 4386: 4382: 4381: 4378: 4377: 4366: 4355: 4344: 4329: 4308: 4303: 4302: 4300: 4299:Classification 4292: 4291:External links 4289: 4286: 4285: 4236: 4181: 4146:(1): e203–14. 4123: 4088: 4045: 4012:(11): 1294–8. 3995: 3946: 3919:(7): 266–271. 3903: 3854: 3805: 3766:Am J Dis Child 3756: 3707: 3650: 3609: 3568: 3505: 3470: 3413: 3364: 3315: 3302: 3263:J Pediatr Surg 3253: 3196: 3183: 3150:(5): 1007–11. 3134: 3085: 3030: 2967: 2926: 2913: 2850: 2837: 2782: 2739: 2704: 2669:(9): 1208–13. 2649: 2600: 2540: 2499: 2455: 2406: 2390: 2333: 2306:(4): 505–524. 2285: 2244:(2): 360–367. 2220: 2176: 2122: 2095:(6): 895–905. 2089:Pediatr Radiol 2074: 2014: 1965: 1930:(11): 2533–8. 1910: 1855: 1782: 1727: 1669: 1614: 1549: 1540: 1531: 1517: 1503: 1470:(3): 291–294. 1451: 1418:(3): 173–181. 1391: 1340: 1333: 1314: 1287: 1258: 1251: 1233: 1214:(7): 266–271. 1198: 1157:(3): 619–624. 1138: 1089: 1061: 1047: 1040: 1022: 1015: 994: 937: 907: 879: 847: 760: 759: 757: 754: 753: 752: 747: 740: 737: 728: 725: 720:PHACE syndrome 710: 707: 698: 695: 689: 686: 673:tufted angioma 632: 629: 623: 620: 614: 611: 567: 564: 560:vasculogenesis 523: 520: 472: 469: 468: 467: 464: 457: 455: 452: 445: 443: 436: 429: 427: 424: 417: 363: 360: 305:PHACE syndrome 257:vascular tumor 239: 238: 235: 231: 230: 217: 211: 210: 207: 203: 202: 192:tufted angioma 177: 171: 170: 167: 161: 160: 145: 139: 138: 135: 131: 130: 127: 123: 122: 108: 102: 101: 95: 89: 88: 75: 69: 68: 64: 63: 55: 54: 51: 47: 46: 38: 26: 9: 6: 4: 3: 2: 4869: 4858: 4855: 4853: 4850: 4848: 4845: 4843: 4840: 4839: 4837: 4817: 4815: 4812: 4809: 4807: 4804: 4801: 4798: 4796: 4793: 4790: 4788: 4785: 4782: 4779: 4777: 4774: 4773: 4771: 4767: 4760: 4757: 4756: 4754: 4750: 4739: 4736: 4733: 4732: 4730: 4728: 4724: 4717: 4714: 4711: 4710: 4708: 4706: 4702: 4695: 4692: 4689: 4686: 4684: 4681: 4678: 4675: 4674: 4672: 4668: 4660: 4657: 4656: 4655: 4652: 4649: 4646: 4644: 4640: 4635: 4634: 4632: 4627: 4624: 4621: 4620: 4618: 4617: 4615: 4609: 4605: 4599:Reticulate CM 4598: 4596: 4593: 4591:Nevus simplex 4590: 4589: 4587: 4583: 4580: 4576: 4573: 4571: 4567: 4557: 4554: 4552: 4549: 4548: 4546: 4542: 4536: 4533: 4532: 4530: 4526: 4520: 4517: 4515: 4512: 4509: 4507: 4504: 4501: 4499: 4496: 4495: 4493: 4489: 4486: 4484: 4480: 4476: 4469: 4464: 4462: 4457: 4455: 4450: 4449: 4446: 4440: 4437: 4435: 4432: 4430: 4427: 4425: 4422: 4421: 4411: 4407: 4406: 4402: 4400: 4396: 4395: 4391: 4390: 4387: 4383: 4376: 4372: 4371: 4367: 4365: 4361: 4360: 4356: 4354: 4350: 4349: 4345: 4343: 4339: 4338: 4334: 4330: 4327: 4323: 4319: 4318: 4314: 4310: 4309: 4306: 4301: 4297: 4281: 4275: 4267: 4263: 4259: 4255: 4252:(3): 348–52. 4251: 4247: 4240: 4232: 4226: 4218: 4214: 4209: 4204: 4200: 4196: 4195:Arch Dermatol 4192: 4185: 4177: 4171: 4163: 4159: 4154: 4149: 4145: 4141: 4137: 4130: 4128: 4119: 4115: 4111: 4107: 4103: 4099: 4092: 4084: 4080: 4076: 4072: 4068: 4064: 4061:(4): 477–93. 4060: 4056: 4049: 4041: 4035: 4027: 4023: 4019: 4015: 4011: 4007: 4006:Arch Dermatol 3999: 3991: 3985: 3977: 3973: 3969: 3965: 3962:(2): 261–85. 3961: 3957: 3950: 3942: 3938: 3934: 3930: 3926: 3922: 3918: 3914: 3907: 3899: 3893: 3885: 3881: 3877: 3873: 3869: 3865: 3858: 3850: 3844: 3836: 3832: 3828: 3824: 3821:(4): 555–60. 3820: 3816: 3809: 3801: 3795: 3787: 3783: 3779: 3775: 3772:(9): 1062–4. 3771: 3767: 3760: 3752: 3746: 3738: 3734: 3730: 3726: 3723:(4): 317–27. 3722: 3718: 3711: 3703: 3697: 3689: 3685: 3681: 3677: 3673: 3669: 3665: 3661: 3660:Dermatol Surg 3654: 3646: 3642: 3637: 3632: 3628: 3624: 3620: 3613: 3605: 3601: 3596: 3591: 3587: 3583: 3582:Arch Dermatol 3579: 3572: 3564: 3558: 3550: 3546: 3542: 3538: 3533: 3528: 3524: 3520: 3516: 3509: 3501: 3497: 3493: 3489: 3485: 3481: 3474: 3466: 3460: 3452: 3448: 3444: 3440: 3436: 3432: 3428: 3424: 3417: 3409: 3403: 3395: 3391: 3387: 3383: 3380:(6): 638–42. 3379: 3375: 3368: 3360: 3354: 3346: 3342: 3338: 3334: 3330: 3326: 3319: 3312: 3306: 3298: 3292: 3284: 3280: 3276: 3272: 3268: 3264: 3257: 3249: 3243: 3235: 3231: 3227: 3223: 3219: 3215: 3211: 3207: 3206:Eur J Pediatr 3200: 3193: 3187: 3179: 3173: 3165: 3161: 3157: 3153: 3149: 3145: 3144:Ophthalmology 3138: 3130: 3124: 3116: 3112: 3108: 3104: 3101:(2): 99–107. 3100: 3096: 3089: 3081: 3075: 3067: 3063: 3058: 3053: 3049: 3045: 3041: 3034: 3026: 3020: 3012: 3008: 3003: 2998: 2994: 2990: 2986: 2982: 2978: 2971: 2963: 2959: 2954: 2949: 2945: 2941: 2937: 2930: 2923: 2917: 2909: 2903: 2895: 2891: 2887: 2883: 2878: 2873: 2870:(8): 735–46. 2869: 2865: 2861: 2854: 2847: 2841: 2833: 2827: 2819: 2815: 2810: 2805: 2801: 2797: 2793: 2786: 2778: 2774: 2770: 2766: 2762: 2758: 2755:(3): 743–52. 2754: 2750: 2743: 2735: 2731: 2727: 2723: 2719: 2715: 2708: 2700: 2694: 2686: 2682: 2677: 2672: 2668: 2664: 2663:Arch Dermatol 2660: 2653: 2645: 2639: 2631: 2627: 2623: 2619: 2616:(6): 962–72. 2615: 2611: 2604: 2596: 2590: 2582: 2578: 2573: 2568: 2564: 2560: 2556: 2549: 2547: 2545: 2536: 2532: 2527: 2522: 2518: 2514: 2510: 2503: 2495: 2491: 2487: 2483: 2479: 2475: 2471: 2467: 2459: 2451: 2447: 2442: 2437: 2433: 2429: 2425: 2421: 2417: 2410: 2404: 2400: 2394: 2386: 2380: 2372: 2368: 2364: 2360: 2356: 2352: 2349:(6): 1090–4. 2348: 2344: 2337: 2329: 2325: 2321: 2317: 2313: 2309: 2305: 2301: 2294: 2292: 2290: 2281: 2275: 2267: 2263: 2259: 2255: 2251: 2247: 2243: 2239: 2231: 2229: 2227: 2225: 2216: 2212: 2207: 2202: 2198: 2194: 2193:Arch Dermatol 2190: 2183: 2181: 2172: 2166: 2158: 2154: 2150: 2146: 2142: 2138: 2131: 2129: 2127: 2118: 2114: 2110: 2106: 2102: 2098: 2094: 2090: 2083: 2081: 2079: 2070: 2064: 2056: 2052: 2048: 2044: 2040: 2036: 2032: 2028: 2027:Arch Dermatol 2021: 2019: 2010: 2006: 2001: 1996: 1992: 1988: 1984: 1980: 1976: 1969: 1961: 1955: 1947: 1943: 1938: 1933: 1929: 1925: 1921: 1914: 1906: 1900: 1892: 1888: 1883: 1878: 1874: 1870: 1869:Ophthalmology 1866: 1859: 1851: 1845: 1837: 1833: 1828: 1823: 1818: 1813: 1809: 1805: 1801: 1797: 1793: 1786: 1778: 1772: 1764: 1760: 1755: 1750: 1746: 1742: 1738: 1731: 1723: 1717: 1709: 1705: 1701: 1697: 1693: 1689: 1686:(3): 245–53. 1685: 1681: 1673: 1665: 1659: 1651: 1647: 1642: 1637: 1634:(2): 308–16. 1633: 1629: 1625: 1618: 1610: 1604: 1596: 1592: 1587: 1582: 1577: 1572: 1569:(4): 807–13. 1568: 1564: 1560: 1553: 1544: 1535: 1527: 1521: 1514:. 2011-09-12. 1513: 1507: 1499: 1493: 1485: 1481: 1477: 1473: 1469: 1465: 1458: 1456: 1447: 1441: 1433: 1429: 1425: 1421: 1417: 1413: 1406: 1404: 1402: 1400: 1398: 1396: 1387: 1383: 1378: 1373: 1368: 1363: 1359: 1355: 1351: 1344: 1336: 1330: 1326: 1325: 1318: 1304: 1300: 1294: 1292: 1277: 1273: 1267: 1265: 1263: 1254: 1248: 1244: 1237: 1229: 1225: 1221: 1217: 1213: 1209: 1202: 1194: 1188: 1180: 1176: 1172: 1168: 1164: 1160: 1156: 1152: 1145: 1143: 1134: 1130: 1125: 1120: 1116: 1112: 1108: 1104: 1100: 1093: 1079:on 2008-07-23 1078: 1074: 1068: 1066: 1057: 1051: 1043: 1041:0-7216-2921-0 1037: 1033: 1026: 1018: 1012: 1008: 1001: 999: 990: 986: 981: 976: 972: 968: 964: 956: 954: 952: 950: 948: 946: 944: 942: 925: 918: 911: 896: 892: 886: 884: 868: 864: 858: 856: 854: 852: 843: 839: 834: 829: 825: 821: 817: 810: 808: 806: 804: 802: 800: 798: 796: 794: 792: 790: 788: 786: 784: 782: 780: 778: 776: 774: 772: 770: 768: 766: 761: 751: 748: 746: 743: 742: 736: 734: 724: 721: 715: 706: 704: 694: 685: 681: 678: 674: 670: 664: 660: 658: 654: 650: 646: 642: 638: 628: 619: 610: 608: 602: 600: 596: 592: 585: 584:H&E stain 580: 572: 563: 561: 557: 553: 549: 545: 541: 537: 533: 529: 519: 517: 512: 510: 504: 502: 498: 497:heart failure 494: 490: 486: 482: 478: 471:Complications 461: 456: 449: 444: 440: 433: 428: 421: 416: 415: 414: 411: 407: 403: 399: 395: 393: 384: 376: 368: 359: 357: 353: 349: 345: 341: 337: 333: 332:benign tumors 328: 327:may be used. 326: 322: 318: 312: 310: 306: 301: 299: 298:heart failure 295: 294:disfigurement 291: 286: 282: 278: 274: 270: 266: 262: 258: 254: 250: 246: 236: 232: 229: 225: 221: 218: 216: 212: 208: 204: 201: 197: 193: 189: 185: 181: 178: 176: 172: 168: 166: 162: 158: 154: 150: 146: 144: 140: 136: 132: 128: 124: 121: 120:disfigurement 117: 116:heart failure 113: 109: 107: 106:Complications 103: 100: 96: 94: 90: 87: 83: 79: 76: 74: 70: 65: 61: 56: 52: 48: 43: 35: 30: 19: 4551:Angiosarcoma 4497: 4403: 4392: 4368: 4357: 4346: 4331: 4311: 4274:cite journal 4249: 4245: 4239: 4225:cite journal 4198: 4194: 4184: 4170:cite journal 4143: 4139: 4104:(1): 120–1. 4101: 4097: 4091: 4058: 4054: 4048: 4034:cite journal 4009: 4005: 3998: 3984:cite journal 3959: 3955: 3949: 3916: 3912: 3906: 3892:cite journal 3867: 3863: 3857: 3843:cite journal 3818: 3814: 3808: 3794:cite journal 3769: 3765: 3759: 3745:cite journal 3720: 3716: 3710: 3696:cite journal 3663: 3659: 3653: 3629:(1): 45–63. 3626: 3622: 3612: 3588:(5): 564–5. 3585: 3581: 3571: 3557:cite journal 3525:(3): 28–31. 3522: 3518: 3508: 3486:(2): 255–6. 3483: 3479: 3473: 3459:cite journal 3429:(2): 245–9. 3426: 3422: 3416: 3402:cite journal 3377: 3373: 3367: 3353:cite journal 3328: 3324: 3318: 3310: 3305: 3291:cite journal 3269:(3): 420–3. 3266: 3262: 3256: 3242:cite journal 3209: 3205: 3199: 3191: 3186: 3172:cite journal 3147: 3143: 3137: 3123:cite journal 3098: 3095:Arch Pediatr 3094: 3088: 3074:cite journal 3047: 3044:N Engl J Med 3043: 3033: 3019:cite journal 2984: 2980: 2970: 2943: 2939: 2929: 2916: 2902:cite journal 2867: 2864:N Engl J Med 2863: 2853: 2845: 2840: 2826:cite journal 2799: 2796:N Engl J Med 2795: 2785: 2752: 2748: 2742: 2720:(1): 141–6. 2717: 2713: 2707: 2693:cite journal 2666: 2662: 2652: 2638:cite journal 2613: 2609: 2603: 2589:cite journal 2562: 2558: 2516: 2512: 2502: 2472:(3): 882–7. 2469: 2465: 2458: 2423: 2419: 2409: 2393: 2379:cite journal 2346: 2342: 2336: 2303: 2299: 2274:cite journal 2241: 2237: 2199:(9): 971–6. 2196: 2192: 2165:cite journal 2143:(1): 11–22. 2140: 2136: 2092: 2088: 2063:cite journal 2030: 2026: 1982: 1978: 1968: 1954:cite journal 1927: 1923: 1913: 1899:cite journal 1875:(4): 633–4. 1872: 1868: 1858: 1844:cite journal 1799: 1795: 1785: 1771:cite journal 1744: 1740: 1730: 1716:cite journal 1683: 1679: 1672: 1658:cite journal 1631: 1627: 1617: 1603:cite journal 1566: 1562: 1552: 1543: 1534: 1520: 1506: 1492:cite journal 1467: 1463: 1440:cite journal 1415: 1411: 1357: 1353: 1343: 1323: 1317: 1306:. Retrieved 1299:"Birthmarks" 1279:. Retrieved 1242: 1236: 1211: 1207: 1201: 1187:cite journal 1154: 1150: 1106: 1102: 1092: 1081:. Retrieved 1077:the original 1073:"Birthmarks" 1050: 1031: 1025: 1006: 970: 966: 928:. Retrieved 923: 915:Workshop I. 910: 898:. Retrieved 894: 871:. Retrieved 869:. 2017-10-20 866: 823: 819: 730: 716: 712: 700: 691: 682: 665: 661: 641:beta-blocker 634: 625: 616: 603: 588: 556:angiogenesis 525: 513: 505: 474: 412: 408: 404: 400: 396: 389: 355: 351: 347: 329: 313: 302: 280: 276: 272: 268: 264: 252: 248: 244: 242: 143:Risk factors 29: 4394:MedlinePlus 3913:Pediatr Rev 3870:(1): 43–6. 1985:(1): 12–9. 1208:Pediatr Rev 727:Terminology 649:propranolol 645:propranolol 317:propranolol 292:formation, 220:Propranolol 126:Usual onset 114:formation, 78:Dermatology 50:Other names 4836:Categories 4370:DiseasesDB 4140:Pediatrics 3331:(1): 4–7. 3212:(4): 344. 2940:Pediatrics 2846:Pediatrics 2559:Pediatrics 2513:Pediatrics 2466:Pediatrics 2343:Acta Cytol 2238:Pediatrics 2137:Hum Pathol 1308:2008-08-02 1281:2008-08-02 1083:2008-08-02 967:Pediatrics 873:2021-04-16 820:Pediatrics 756:References 745:Hemangioma 631:Medication 591:ultrasound 536:hypothesis 509:surgically 477:ulceration 392:Caucasians 215:Medication 4740:In CM-AVM 4718:In CM-AVM 4676:Common VM 4544:Malignant 4405:eMedicine 3941:245154941 3815:J Pediatr 3192:J Pediatr 3050:(1): 69. 2894:205096769 2714:J Pediatr 1464:J Pediatr 900:7 January 709:Prognosis 622:Treatment 566:Diagnosis 493:amblyopia 489:breathing 234:Frequency 206:Treatment 147:Females, 73:Specialty 4752:Combined 4734:Sporadic 4712:Sporadic 4410:derm/201 4328:D18.010) 4266:15780229 4217:11735711 4162:26055853 4075:12664009 4026:22910902 3976:18068263 3737:12873458 3688:31998819 3680:19889007 3645:21095471 3604:20479314 3549:37378654 3541:22150436 3500:20142555 3451:42948411 3443:22471694 3283:10726680 3234:40056042 3226:10206141 3164:17337066 3115:14761730 3011:29667726 2962:26772662 2886:25693013 2818:18550886 2777:35163645 2769:21572374 2685:11559219 2630:11369908 2581:26416931 2535:30584062 2494:31052666 2486:16950977 2450:28766950 2363:11127741 2328:12205301 2320:17590939 2258:18676554 2215:20855695 2157:10665907 2117:21550296 2109:20432007 2047:12472344 2009:23668474 1946:16902414 1891:11949625 1836:16365311 1763:17872454 1708:23717344 1700:21517952 1650:18174492 1595:18223093 1484:17307549 1432:10403856 1386:20525327 1179:25687867 1171:22575857 1133:34325500 989:30584062 930:23 March 842:26416931 739:See also 540:placenta 528:estrogen 481:bleeding 321:steroids 237:Up to 5% 228:steroids 198:, other 93:Symptoms 4364:D006391 4353:M9120/0 4118:7089103 4083:4814838 3933:8084847 3884:8288807 3835:1552392 3786:1877568 3394:8644806 3345:8455125 3066:7777010 3002:6513200 2734:8551406 2441:5963373 2371:3376037 2266:5646275 2000:3707963 1827:1323205 1804:Bibcode 1586:7978195 1377:2903548 1228:8084847 1124:8566800 926:. ISSVA 688:Surgery 653:placebo 595:Doppler 532:hypoxia 352:angeion 261:anomaly 224:Timolol 4737:In HHT 4715:In HHT 4641:LM in 4578:Simple 4491:Benign 4399:001459 4342:757.32 4264:  4215:  4160:  4116:  4081:  4073:  4024:  3974:  3939:  3931:  3882:  3833:  3784:  3735:  3686:  3678:  3643:  3602:  3547:  3539:  3498:  3449:  3441:  3392:  3343:  3281:  3232:  3224:  3162:  3113:  3064:  3009:  2999:  2960:  2892:  2884:  2816:  2775:  2767:  2732:  2683:  2628:  2579:  2533:  2492:  2484:  2448:  2438:  2401:  2369:  2361:  2326:  2318:  2264:  2256:  2213:  2155:  2115:  2107:  2055:521202 2053:  2045:  2007:  1997:  1944:  1889:  1834:  1824:  1761:  1706:  1698:  1648:  1628:Stroke 1593:  1583:  1482:  1430:  1384:  1374:  1331:  1249:  1226:  1177:  1169:  1131:  1121:  1038:  1013:  987:  867:nhs.uk 840:  522:Causes 485:larynx 342:, and 336:whites 285:lesion 159:babies 149:whites 99:lesion 4375:30032 4348:ICD-O 4322:D18.0 4079:S2CID 3937:S2CID 3684:S2CID 3545:S2CID 3447:S2CID 3230:S2CID 2890:S2CID 2773:S2CID 2490:S2CID 2367:S2CID 2324:S2CID 2262:S2CID 2113:S2CID 2051:S2CID 1704:S2CID 1360:: 7. 1175:S2CID 920:(PDF) 733:tumor 697:Laser 613:Liver 593:with 439:scalp 348:haima 296:, or 290:ulcer 134:Types 112:ulcer 4359:MeSH 4337:9-CM 4326:ILDS 4280:link 4262:PMID 4231:link 4213:PMID 4176:link 4158:PMID 4114:PMID 4071:PMID 4040:link 4022:PMID 3990:link 3972:PMID 3929:PMID 3898:link 3880:PMID 3849:link 3831:PMID 3800:link 3782:PMID 3751:link 3733:PMID 3702:link 3676:PMID 3641:PMID 3600:PMID 3563:link 3537:PMID 3496:PMID 3465:link 3439:PMID 3408:link 3390:PMID 3359:link 3341:PMID 3297:link 3279:PMID 3248:link 3222:PMID 3178:link 3160:PMID 3129:link 3111:PMID 3080:link 3062:PMID 3025:link 3007:PMID 2985:2018 2958:PMID 2908:link 2882:PMID 2832:link 2814:PMID 2765:PMID 2730:PMID 2699:link 2681:PMID 2644:link 2626:PMID 2595:link 2577:PMID 2531:PMID 2482:PMID 2446:PMID 2399:ISBN 2385:link 2359:PMID 2316:PMID 2280:link 2254:PMID 2211:PMID 2171:link 2153:PMID 2105:PMID 2069:link 2043:PMID 2005:PMID 1960:link 1942:PMID 1905:link 1887:PMID 1850:link 1832:PMID 1777:link 1759:PMID 1722:link 1696:PMID 1664:link 1646:PMID 1609:link 1591:PMID 1498:link 1480:PMID 1446:link 1428:PMID 1382:PMID 1329:ISBN 1247:ISBN 1224:PMID 1193:link 1167:PMID 1129:PMID 1036:ISBN 1011:ISBN 985:PMID 932:2022 902:2019 838:PMID 671:and 558:and 501:bone 356:-oma 275:and 4333:ICD 4313:ICD 4254:doi 4203:doi 4199:137 4148:doi 4144:136 4106:doi 4063:doi 4014:doi 4010:148 3964:doi 3921:doi 3872:doi 3823:doi 3819:120 3774:doi 3770:145 3725:doi 3668:doi 3631:doi 3590:doi 3586:146 3527:doi 3488:doi 3484:128 3431:doi 3382:doi 3378:121 3333:doi 3271:doi 3214:doi 3210:158 3152:doi 3148:114 3103:doi 3052:doi 3048:333 2997:PMC 2989:doi 2948:doi 2944:137 2872:doi 2868:372 2804:doi 2800:358 2757:doi 2753:128 2722:doi 2718:128 2671:doi 2667:137 2618:doi 2567:doi 2563:136 2521:doi 2517:143 2474:doi 2470:118 2436:PMC 2428:doi 2351:doi 2308:doi 2246:doi 2242:122 2201:doi 2197:146 2145:doi 2097:doi 2035:doi 2031:138 1995:PMC 1987:doi 1983:169 1932:doi 1928:126 1877:doi 1873:109 1822:PMC 1812:doi 1800:102 1749:doi 1688:doi 1636:doi 1581:PMC 1571:doi 1472:doi 1468:150 1420:doi 1416:341 1372:PMC 1362:doi 1216:doi 1159:doi 1155:130 1119:PMC 1111:doi 975:doi 971:143 828:doi 824:136 607:MRI 552:DNA 546:of 319:or 271:", 267:, " 259:or 243:An 4838:: 4408:: 4397:: 4373:: 4362:: 4351:: 4340:: 4320:: 4317:10 4276:}} 4272:{{ 4260:. 4250:58 4248:. 4227:}} 4223:{{ 4211:. 4197:. 4193:. 4172:}} 4168:{{ 4156:. 4142:. 4138:. 4126:^ 4112:. 4102:70 4100:. 4077:. 4069:. 4059:48 4057:. 4036:}} 4032:{{ 4020:. 4008:. 3986:}} 3982:{{ 3970:. 3960:58 3958:. 3935:. 3927:. 3917:15 3915:. 3894:}} 3890:{{ 3878:. 3868:20 3866:. 3845:}} 3841:{{ 3829:. 3817:. 3796:}} 3792:{{ 3780:. 3768:. 3747:}} 3743:{{ 3731:. 3721:56 3719:. 3698:}} 3694:{{ 3682:. 3674:. 3664:35 3662:. 3639:. 3627:38 3625:. 3621:. 3598:. 3584:. 3580:. 3559:}} 3555:{{ 3543:. 3535:. 3523:29 3521:. 3517:. 3494:. 3482:. 3461:}} 3457:{{ 3445:. 3437:. 3427:30 3425:. 3404:}} 3400:{{ 3388:. 3376:. 3355:}} 3351:{{ 3339:. 3329:30 3327:. 3293:}} 3289:{{ 3277:. 3267:35 3265:. 3244:}} 3240:{{ 3228:. 3220:. 3208:. 3174:}} 3170:{{ 3158:. 3146:. 3125:}} 3121:{{ 3109:. 3099:11 3097:. 3076:}} 3072:{{ 3060:. 3046:. 3042:. 3021:}} 3017:{{ 3005:. 2995:. 2983:. 2979:. 2956:. 2942:. 2938:. 2904:}} 2900:{{ 2888:. 2880:. 2866:. 2862:. 2828:}} 2824:{{ 2812:. 2798:. 2794:. 2771:. 2763:. 2751:. 2728:. 2716:. 2695:}} 2691:{{ 2679:. 2665:. 2661:. 2640:}} 2636:{{ 2624:. 2614:44 2612:. 2591:}} 2587:{{ 2575:. 2561:. 2557:. 2543:^ 2529:. 2515:. 2511:. 2488:. 2480:. 2468:. 2444:. 2434:. 2424:90 2422:. 2418:. 2381:}} 2377:{{ 2365:. 2357:. 2347:44 2345:. 2322:. 2314:. 2302:. 2288:^ 2276:}} 2272:{{ 2260:. 2252:. 2240:. 2223:^ 2209:. 2195:. 2191:. 2179:^ 2167:}} 2163:{{ 2151:. 2141:31 2139:. 2125:^ 2111:. 2103:. 2093:40 2091:. 2077:^ 2065:}} 2061:{{ 2049:. 2041:. 2029:. 2017:^ 2003:. 1993:. 1981:. 1977:. 1956:}} 1952:{{ 1940:. 1926:. 1922:. 1901:}} 1897:{{ 1885:. 1871:. 1867:. 1846:}} 1842:{{ 1830:. 1820:. 1810:. 1798:. 1794:. 1773:}} 1769:{{ 1757:. 1745:27 1743:. 1739:. 1718:}} 1714:{{ 1702:. 1694:. 1684:28 1682:. 1660:}} 1656:{{ 1644:. 1632:39 1630:. 1626:. 1605:}} 1601:{{ 1589:. 1579:. 1567:29 1565:. 1561:. 1494:}} 1490:{{ 1478:. 1466:. 1454:^ 1442:}} 1438:{{ 1426:. 1414:. 1394:^ 1380:. 1370:. 1356:. 1352:. 1301:. 1290:^ 1274:. 1261:^ 1222:. 1212:15 1210:. 1189:}} 1185:{{ 1173:. 1165:. 1153:. 1141:^ 1127:. 1117:. 1107:64 1105:. 1101:. 1064:^ 997:^ 983:. 969:. 965:. 940:^ 922:. 893:. 882:^ 865:. 850:^ 836:. 822:. 818:. 764:^ 675:. 597:, 487:, 338:, 249:IH 226:, 222:, 194:, 190:, 186:, 182:, 155:, 151:, 118:, 84:, 80:, 4467:e 4460:t 4453:v 4335:- 4324:( 4315:- 4305:D 4282:) 4268:. 4256:: 4233:) 4219:. 4205:: 4178:) 4164:. 4150:: 4120:. 4108:: 4085:. 4065:: 4042:) 4028:. 4016:: 3992:) 3978:. 3966:: 3943:. 3923:: 3900:) 3886:. 3874:: 3851:) 3837:. 3825:: 3802:) 3788:. 3776:: 3753:) 3739:. 3727:: 3704:) 3690:. 3670:: 3647:. 3633:: 3606:. 3592:: 3565:) 3551:. 3529:: 3502:. 3490:: 3467:) 3453:. 3433:: 3410:) 3396:. 3384:: 3361:) 3347:. 3335:: 3299:) 3285:. 3273:: 3250:) 3236:. 3216:: 3180:) 3166:. 3154:: 3131:) 3117:. 3105:: 3082:) 3068:. 3054:: 3027:) 3013:. 2991:: 2964:. 2950:: 2910:) 2896:. 2874:: 2834:) 2820:. 2806:: 2779:. 2759:: 2736:. 2724:: 2701:) 2687:. 2673:: 2646:) 2632:. 2620:: 2597:) 2583:. 2569:: 2537:. 2523:: 2496:. 2476:: 2452:. 2430:: 2387:) 2373:. 2353:: 2330:. 2310:: 2304:9 2282:) 2268:. 2248:: 2217:. 2203:: 2173:) 2159:. 2147:: 2119:. 2099:: 2071:) 2057:. 2037:: 2011:. 1989:: 1962:) 1948:. 1934:: 1907:) 1893:. 1879:: 1852:) 1838:. 1814:: 1806:: 1779:) 1765:. 1751:: 1724:) 1710:. 1690:: 1666:) 1652:. 1638:: 1611:) 1597:. 1573:: 1528:. 1500:) 1486:. 1474:: 1448:) 1434:. 1422:: 1388:. 1364:: 1358:6 1337:. 1311:. 1284:. 1255:. 1230:. 1218:: 1195:) 1181:. 1161:: 1135:. 1113:: 1086:. 1058:. 1044:. 1019:. 991:. 977:: 934:. 904:. 876:. 844:. 830:: 247:( 36:. 20:)

Index

Capillary hemangioma
Hepatic hemangioma

Specialty
Dermatology
gastroenterology
Oral and Maxillofacial Surgery
Symptoms
lesion
Complications
ulcer
heart failure
disfigurement
Risk factors
whites
premature birth
low birth weight
Diagnostic method
Differential diagnosis
Congenital hemangioma
pyogenic granuloma
kaposiform hemangioendothelioma
tufted angioma
venous malformation
vascular anomaly
Medication
Propranolol
Timolol
steroids
vascular tumor

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑